Data Collection Protocol for Patients With Von Hippel Lindau Disease
Sponsor: M.D. Anderson Cancer Center
Listed as NCT05955014, this observational or N/A phase trial focuses on Von Hippel Lindau Disease and remains actively recruiting participants. Sponsored by M.D. Anderson Cancer Center, it has been updated 8 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Dec 2025 — Present [monthly]
Recruiting
-
Jun 2025 — Dec 2025 [monthly]
Recruiting
-
Nov 2024 — Jun 2025 [monthly]
Recruiting
-
Sep 2024 — Nov 2024 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
▶ Show 3 earlier versions
-
May 2024 — Jul 2024 [monthly]
Recruiting
-
Sep 2023 — May 2024 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Aug 2023 — Sep 2023 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- M.D. Anderson Cancer Center
For direct contact, visit the study record on ClinicalTrials.gov .